CARTANA is a Swedish Biotechnology company that maps gene expression in tissue via In Situ Sequencing (ISS), the next generation of sequencing technologies.
Our solution enables simultaneous analysis of hundreds of genes within all cells comprising a tissue, without losing tissue morphology, with high specificity and throughput in several research areas.
- Revolutionary research and biomarker discovery
- Treatment validation
- Future diagnostic tool
Neuroscience, Immunology, and Oncology.
In Situ Sequencing technology comprises
- a new sample & library preparation part,
- a new probe barcoding design,
- a novel sequencing method.
The result is a map of gene expression data of all analyzed genes and their abundance with sub-cellular resolution on top of the natural morphology of the tissue section.
Discover The Future
We are a multi-disciplinary laboratory
committed to the advancement of biology.